Literature DB >> 27973971

Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report.

Alfredo Niro1, Nicola Recchimurzo1, Alessandra Sborgia1, Michele Guida2, Giovanni Alessio1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27973971     DOI: 10.1080/09273948.2016.1261166

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  3 in total

Review 1.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

Review 2.  Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.

Authors:  Lucie Heinzerling; Thomas K Eigentler; Michael Fluck; Jessica C Hassel; Daniela Heller-Schenck; Jan Leipe; Matthias Pauschinger; Arndt Vogel; Lisa Zimmer; Ralf Gutzmer
Journal:  ESMO Open       Date:  2019-05-23

3.  Retinal Vein Occlusion in a Patient on Dabrafenib and Trametinib Therapy for Metastatic Melanoma.

Authors:  Mercedes Molero-Senosiain; Maria Liseth Salazar; Irene Camacho; Blanca Benito-Pascual; Clara Valor-Suarez
Journal:  Cureus       Date:  2022-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.